← Back to Clinical Trials
Recruiting NCT06438549

NCT06438549 Integrating CHWs Into Prenatal Care for Maternal Smoking Cessation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06438549
Status Recruiting
Phase
Sponsor Loma Linda University
Condition Tobacco Use
Study Type INTERVENTIONAL
Enrollment 105 participants
Start Date 2024-05-24
Primary Completion 2026-05

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
HCP-CHW Integration into Prenatal Care for Smoking CessationControl Arm

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 105 participants in total. It began in 2024-05-24 with a primary completion date of 2026-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This develops a novel behavioral tobacco cessation program for pregnant smokers in San Bernardino County.

Eligibility Criteria

Inclusion Criteria: * \< 24 weeks pregnant * age \> 18 years, * current smokers (100 cigarettes in their lifetime and \>3 cigarettes per day in the last 7 days; including poly-tobacco use, combining cigarettes with non-combustible products) confirmed by expired carbon monoxide (CO) * willing to quit smoking and set a quit date in the next 2 weeks upon enrolling * enrolled in prenatal care at Loma Linda University Health (LLUH) or Riverside University Health System (RUHS) Exclusion Criteria: * severe mental health problems that prevent informed consent and/or CHW intervention * women who were on Nicotine Replacement Therapy (NRT) or enrolled in a cessation program within 30 days * unwillingness to participate in audio-recorded key informant interviews or focus groups

Contact & Investigator

Central Contact

Anne Berit Petersen

✉ abpetersen@llu.edu

📞 909 558 1000

Principal Investigator

Anne Berit Petersen, PhD

PRINCIPAL INVESTIGATOR

Loma Linda University

Frequently Asked Questions

Who can join the NCT06438549 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Tobacco Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06438549 currently recruiting?

Yes, NCT06438549 is actively recruiting participants. Contact the research team at abpetersen@llu.edu for enrollment information.

Where is the NCT06438549 trial being conducted?

This trial is being conducted at Loma Linda, United States, Moreno Valley, United States.

Who is sponsoring the NCT06438549 clinical trial?

NCT06438549 is sponsored by Loma Linda University. The principal investigator is Anne Berit Petersen, PhD at Loma Linda University. The trial plans to enroll 105 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology